Thursday, September 02, 2010

Gynocological Cancer

GOG 0218	Lead group: GOG
A Phase III Trial of Carboplatin and Paclitaxel Plus Placebo Versus Carboplatin and Palitaxel Plus Concurrent Bevacizumab Followed by Placebo, Versus Carboplatin and Paclitaxel Plus Concurrent And Extended Bevacizumab, in Women with Newly Diagnosed, Previously Untreated, Stage III or IV, Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer

We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.

For more information about the clinical trials listed please go to http://www.clinicaltrials.gov.